Bridgeway Capital Management’s Crescent Biopharma, Inc. Common Stock CBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-818
| Closed | -$23K | – | 1286 |
|
|
2024
Q2 | $23K | Sell |
818
-868
| -51% | -$24.4K | ﹤0.01% | 1252 |
|
|
2024
Q1 | $506K | Sell |
1,686
-286
| -15% | -$85.8K | 0.01% | 921 |
|
|
2023
Q4 | $465K | Buy |
1,972
+250
| +15% | +$59K | 0.01% | 956 |
|
|
2023
Q3 | $258K | Buy |
1,722
+363
| +27% | +$54.5K | 0.01% | 1042 |
|
|
2023
Q2 | $236K | Buy |
1,359
+255
| +23% | +$44.4K | 0.01% | 1096 |
|
|
2023
Q1 | $139K | Buy |
1,104
+300
| +37% | +$37.8K | ﹤0.01% | 1172 |
|
|
2022
Q4 | $244K | Sell |
804
-750
| -48% | -$227K | 0.01% | 1036 |
|
|
2022
Q3 | $86K | Hold |
1,554
| – | – | ﹤0.01% | 1300 |
|
|
2022
Q2 | $93K | Hold |
1,554
| – | – | ﹤0.01% | 1235 |
|
|
2022
Q1 | $177K | Hold |
1,554
| – | – | ﹤0.01% | 1190 |
|
|
2021
Q4 | $224K | Sell |
1,554
-133
| -8% | -$19.2K | ﹤0.01% | 1145 |
|
|
2021
Q3 | $369K | Sell |
1,687
-470
| -22% | -$103K | 0.01% | 1120 |
|
|
2021
Q2 | $500K | Buy |
2,157
+450
| +26% | +$104K | 0.01% | 1067 |
|
|
2021
Q1 | $514K | Sell |
1,707
-345
| -17% | -$104K | 0.01% | 1079 |
|
|
2020
Q4 | $772K | Sell |
2,052
-39
| -2% | -$14.7K | 0.02% | 806 |
|
|
2020
Q3 | $642K | Sell |
2,091
-1,809
| -46% | -$555K | 0.01% | 809 |
|
|
2020
Q2 | $1.47M | Buy |
3,900
+1,348
| +53% | +$507K | 0.03% | 538 |
|
|
2020
Q1 | $582K | Buy |
2,552
+1,582
| +163% | +$361K | 0.01% | 710 |
|
|
2019
Q4 | $513K | Sell |
970
-684
| -41% | -$362K | 0.01% | 987 |
|
|
2019
Q3 | $713K | Buy |
+1,654
| New | +$713K | 0.01% | 827 |
|
|
2018
Q2 | – | Sell |
-200
| Closed | -$325K | – | 1431 |
|
|
2018
Q1 | $325K | Sell |
200
-168
| -46% | -$273K | ﹤0.01% | 1186 |
|
|
2017
Q4 | $617K | Sell |
368
-300
| -45% | -$503K | 0.01% | 1028 |
|
|
2017
Q3 | $934K | Hold |
668
| – | – | 0.01% | 865 |
|
|
2017
Q2 | $745K | Hold |
668
| – | – | 0.01% | 949 |
|
|
2017
Q1 | $363K | Sell |
668
-150
| -18% | -$81.5K | ﹤0.01% | 1157 |
|
|
2016
Q4 | $499K | Sell |
818
-280
| -26% | -$171K | 0.01% | 1092 |
|
|
2016
Q3 | $785K | Hold |
1,098
| – | – | 0.01% | 900 |
|
|
2016
Q2 | $798K | Hold |
1,098
| – | – | 0.01% | 866 |
|
|
2016
Q1 | $654K | Hold |
1,098
| – | – | 0.01% | 934 |
|
|
2015
Q4 | $628K | Buy |
1,098
+395
| +56% | +$226K | 0.01% | 969 |
|
|
2015
Q3 | $393K | Buy |
703
+100
| +17% | +$55.9K | 0.01% | 1140 |
|
|
2015
Q2 | $479K | Buy |
603
+224
| +59% | +$178K | 0.01% | 1091 |
|
|
2015
Q1 | $315K | Buy |
379
+83
| +28% | +$69K | 0.01% | 1247 |
|
|
2014
Q4 | $213K | Buy |
296
+66
| +29% | +$47.5K | ﹤0.01% | 1293 |
|
|
2014
Q3 | $160K | Buy |
+230
| New | +$160K | ﹤0.01% | 1368 |
|